PAHC has been the topic of a number of other reports. Guggenheim set a $30.00 target price on Phibro Animal Health Corp. and gave the stock a buy rating in a research report on Monday, September 12th. Zacks Investment Research raised Phibro Animal Health Corp. from a strong sell rating to a hold rating in a research report on Tuesday, July 12th. Credit Suisse Group AG reissued a buy rating and set a $29.00 target price on shares of Phibro Animal Health Corp. in a research report on Tuesday, August 30th. Finally, Morgan Stanley set a $23.00 target price on Phibro Animal Health Corp. and gave the stock a sell rating in a research report on Sunday, September 4th. Three investment analysts have rated the stock with a sell rating, one has assigned a hold rating and three have issued a buy rating to the company’s stock. Phibro Animal Health Corp. currently has a consensus rating of Hold and a consensus target price of $30.67.
Shares of Phibro Animal Health Corp. (NASDAQ:PAHC) opened at 27.34 on Friday. The firm has a market capitalization of $1.08 billion, a PE ratio of 13.21 and a beta of 1.35. The stock’s 50 day moving average price is $24.95 and its 200-day moving average price is $22.10. Phibro Animal Health Corp. has a 12 month low of $16.80 and a 12 month high of $35.69.
Phibro Animal Health Corp. (NASDAQ:PAHC) last issued its quarterly earnings results on Monday, August 29th. The company reported $0.40 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.38 by $0.02. The company had revenue of $189.20 million for the quarter. Phibro Animal Health Corp. had a return on equity of 105.21% and a net margin of 11.02%. The company’s revenue for the quarter was up 2.3% compared to the same quarter last year. During the same period in the prior year, the business posted $0.44 earnings per share. On average, equities analysts anticipate that Phibro Animal Health Corp. will post $1.41 earnings per share for the current fiscal year.
The business also recently disclosed a quarterly dividend, which was paid on Wednesday, September 28th. Shareholders of record on Wednesday, September 7th were issued a dividend of $0.10 per share. This represents a $0.40 dividend on an annualized basis and a yield of 1.46%. The ex-dividend date of this dividend was Friday, September 2nd. Phibro Animal Health Corp.’s payout ratio is 19.42%.
A number of large investors have recently added to or reduced their stakes in the stock. Guggenheim Capital LLC increased its stake in Phibro Animal Health Corp. by 0.7% in the second quarter. Guggenheim Capital LLC now owns 21,957 shares of the company’s stock worth $410,000 after buying an additional 150 shares during the last quarter. Arizona State Retirement System boosted its position in Phibro Animal Health Corp. by 3.3% in the first quarter. Arizona State Retirement System now owns 9,400 shares of the company’s stock worth $254,000 after buying an additional 300 shares during the period. Numeric Investors LLC boosted its position in Phibro Animal Health Corp. by 0.4% in the second quarter. Numeric Investors LLC now owns 67,600 shares of the company’s stock worth $1,261,000 after buying an additional 300 shares during the period. American International Group Inc. boosted its position in Phibro Animal Health Corp. by 4.2% in the second quarter. American International Group Inc. now owns 13,909 shares of the company’s stock worth $260,000 after buying an additional 564 shares during the period. Finally, Nationwide Fund Advisors boosted its position in Phibro Animal Health Corp. by 5.6% in the second quarter. Nationwide Fund Advisors now owns 11,921 shares of the company’s stock worth $222,000 after buying an additional 637 shares during the period. 47.88% of the stock is currently owned by institutional investors.
About Phibro Animal Health Corp.
Phibro Animal Health Corporation is an animal health and mineral nutrition company. The Company is engaged in developing, manufacturing and marketing products for a range of food animals, including poultry, swine, beef and dairy cattle, and aquaculture. The Company operates through three segments: Animal Health, Mineral Nutrition and Performance Products.
Receive News & Ratings for Phibro Animal Health Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phibro Animal Health Corp. and related companies with MarketBeat.com's FREE daily email newsletter.